New dressing uses gas to heal stubborn wounds

NCT ID NCT06640985

Ongoing Disease control Sponsor: ConvaTec Inc. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a special dressing called EDX110 on 43 people with hard-to-heal wounds from diabetes or poor leg circulation. The dressing creates a gas called nitric oxide to help clean and heal the wound. Researchers will measure how much the wound shrinks over 12 weeks and how it affects quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: EDX110 wound dressing system
What this could lead to: If it works, this dressing could offer a new way to help heal stubborn diabetic foot and venous leg ulcers, potentially reducing wound size and improving quality of life.
What could go wrong: This is a small, early case series with no control group, so results may not apply broadly. The dressing may not work for all wound types, and individual healing varies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC FOOT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic venous insufficiency Diabetic Foot injury ulcer of lower limbs Varicose Ulcer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETIC FOOT FOOT ULCER, DIABETIC VENOUS ULCER WOUND HEALING

Contacts and locations

Show contact details

Locations

Convatec Medical Care

Santiago, Chile

More trials for these conditions

Other studies related to the condition(s) this trial covers.